Korea secures COVID-19 vaccines for 44 million people
Woman holds vials labelled "COVID-19 Coronavirus Vaccine" over dry ice in this illustration taken on Dec. 5, 2020. ReutersSouth Korea has secured early access of COVID-19 vaccines developed by four pharmaceutical companies and from a global vaccine project for 44 million people, the health ministry said Tuesday. The Ministry of Health and Welfare said it has preordered 64 million doses of vaccines by four drugmakers -- AstraZeneca Inc., Pfizer, Johnson Johnson's Janssen and Moderna -- for 34 million people.The World Health Organization's global vaccine project, known as COVAX, will supply the vaccine of AstraZeneca, Pfizer and Sanopi for 10 million people.The government will each purchase 20 million doses from AstraZeneca, Pfizer and Moderna, which requires two shots, and buy 4 million doses from Johnson Johnson's Janssen, which requires one shot. The ministry said it has already signed a deal with AstraZeneca and will ink contracts with three other companies later this month, adding it has set aside 1.3 trillion won (US$1.2 billion) of its budget for the vaccine purchase.The preorde
Dec 8, 2020